KRG-mediated health-improving effects such as anti-cancer, anti-diabetes, and anti-inflammation effects have been reported to be related to the insulin/IGF-1 signaling (IIS) pathway [33–35], and downregulation of IIS has been reported to increase lifespan in many model organisms [36, 37]. This evidence concerns the gene SCGB1D4 and cancer.